Related Experiment Videos
A simple technic for predicting daily maintenance dose of warfarin
American Journal of Surgery
|April 1, 1979
Summary
This study developed a new algorithm to predict the daily warfarin maintenance dose using the area under the curve (AREA) of prothrombin time. The method accurately estimates warfarin dosage, improving patient treatment.
Area of Science:
- Pharmacology
- Clinical Medicine
- Biostatistics
Background:
- Warfarin is a common anticoagulant requiring careful dosage management.
- Predicting the optimal daily maintenance dose of warfarin can be challenging.
- Accurate warfarin dosing is crucial for therapeutic efficacy and patient safety.
Purpose of the Study:
- To develop and validate an algorithm for predicting the daily maintenance dose of warfarin.
- To utilize prothrombin time data to establish a predictive model for warfarin dosing.
- To assess the accuracy and utility of the developed algorithm in a prospective setting.
Main Methods:
- Retrospective analysis of warfarin anticoagulation data from 47 patients.
- Calculation of the area under the curve (AREA) from prothrombin time vs. cumulative warfarin loading dose plots.
- Derivation of a linear regression model: Daily maintenance dose (mg/day) = 0.0465 x (AREA) + 1.5.
- Prospective validation of the algorithm in 24 patients.
Main Results:
- A significant linear correlation was found between the daily maintenance dose and AREA.
- The derived algorithm successfully predicted warfarin maintenance doses.
- In the prospective study, the mean prothrombin time during stabilization was 21.5 +/- 2.2 seconds, with individual patient means between 19-24 seconds.
- The developed method demonstrated utility in early and accurate prediction of warfarin maintenance dose.
Conclusions:
- The developed algorithm provides a reliable method for predicting the daily maintenance dose of warfarin.
- This technique aids in the early and accurate determination of warfarin dosage, potentially improving anticoagulation management.
- The study highlights the clinical applicability of using prothrombin time-derived metrics for personalized warfarin dosing.